查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
藥物器械組合產品市場：按產品類型、應用、最終用戶、地區 - 規模、份額、展望、機會分析，2022-2028 年
市場調查報告書
商品編碼
1181744

藥物器械組合產品市場：按產品類型、應用、最終用戶、地區 - 規模、份額、展望、機會分析，2022-2028 年

Drug Device Combination Product Market, By Products Type, By Application, By End-User, and By Geography - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028
出版日期: | 出版商: Coherent Market Insights | 英文 201 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

組合產品是將藥物、醫療器械和生物製劑組合在一起以實現更安全、更有效治療的治療/診斷產品。 組合產品是將至少兩種產品（一種醫療器械和一種藥物）結合起來共同治療的產品。 因此，對結合醫療器械和藥品的產品的需求正在增加。

市場動態

慢性病負擔加重、老年人口不斷增加、確保患者安全的有利政府政策和舉措、COVID-19（大流行）爆發以及市場參與者推出新產品是預計將推動全球增長的主要因素預測期內的藥物器械組合產品市場。

例如，根據美國疾病控制與預防中心 (CDC) 的數據，美國每 10 人中就有 6 人至少患有一種慢性疾病，例如心髒病、中風、癌症或糖尿病。 這些和其他慢性病是美國死亡和殘疾的主要原因，也是醫療保健費用的主要原因。

此外，2020 年 10 月，美敦力 (Medtronic) 的 Abre 靜脈自擴張支架系統獲得了美國食品藥品監督管理局 (FDA) 的批准。 該系統適用於有症狀的髂股流出道阻塞患者的髂股靜脈。

這項研究的主要特點

  • 本報告對全球藥物器械組合產品市場進行了深入分析，提供了以 2021 年為基準年的預測期（2022-2028 年）的市場規模和復合年增長率 (CAGR%)。它提供。
  • 解釋了不同細分市場的潛在創收機會，並描述了針對該市場的有吸引力的投資建議矩陣。
  • 它還提供了有關市場驅動因素、制約因素、機會、新產品發布或批准、市場趨勢、區域前景、主要參與者採用的競爭戰略等方面的重要見解。
  • 它根據以下參數（包括公司亮點、產品組合、主要亮點、財務業績和戰略）介紹了全球藥械組合產品市場的主要參與者。
  • 本研究涵蓋的主要公司包括 AbbVie Inc.（Allergan）、Terumo Corporation、GlaxoSmithKline PLC、Novartis AG、Medtronic PLC、Abbott Laboratories、Boston Scientific Corp.、W L Gore and Associates Inc.、Stryker Corporation 和Becton、Dickinson and Company 等。
  • 這份報告中的見解將使營銷人員和企業高管能夠就未來的產品發布、類型升級、市場擴張和營銷策略做出明智的決策。我猜。
  • 本研究報告面向該行業的各種利益相關者，包括投資者、供應商、產品製造商、分銷商、新進入者和金融分析師。
  • 利益相關者可以通過用於分析全球藥物器械組合產品市場的各種戰略矩陣來促進決策制定。

內容

第 1 章目的和先決條件

  • 調查目的
  • 先決條件
  • 縮寫說明

第二章市場展望

  • 報告內容
    • 市場定義和範圍
  • 執行摘要
    • 市場概況：按產品分類
    • 市場概況：按應用分類
    • 市場概況：按最終用戶分類
    • 市場概況：按地區
  • 連貫機會圖 (COM)

第3章市場動態、規律及趨勢分析

  • 市場動態
    • 慢性病負擔增加
    • 產品召回和相關並發症
    • COVID-19（全球大流行）爆發
  • 影響分析
  • 主要亮點
  • 監管情景
  • 產品發布/批准
  • 害蟲分析
  • 對 PORTER 的分析
  • 合併/收購場景

第 4 章全球藥物器械組合產品市場 - 冠狀病毒 (COVID-19) 大流行的影響

  • COVID-19 的流行病學特徵
  • 供應方和需求方分析
  • 經濟影響

第 5 章全球藥物器械組合產品市場，按產品分類，2017-2028

  • 藥物洗脫支架
  • 透皮貼劑
  • 輸液泵
  • 藥物洗脫球囊
  • 吸入器
  • 其他產品

第 6 章：2017-2028 年按應用分列的藥械組合產品全球市場

  • 心血管
  • 糖尿病治療
  • 癌症治療
  • 呼吸系統疾病
  • 其他應用領域

第 7 章全球藥物-器械組合市場，按最終用戶，2017-2028

  • 醫院
  • 門診手術中心
  • 其他最終用戶

第 8 章：2017-2028 年按地區分列的全球藥械組合產品市場

  • 北美
  • 歐洲
  • 亞太地區
  • 拉丁美洲
  • 中東和非洲
  • 世界其他地區

第9章競爭格局

  • AbbVie Inc.（Allergan）
  • Terumo Corporation
  • GlaxoSmithKline PLC
  • Novartis AG
  • Medtronic PLC
  • Abbott Laboratories
  • Boston Scientific Corp.
  • W L Gore and Associates Inc.
  • Stryker Corporation
  • Becton, Dickinson and Company

第 10 章

  • 調查方法介紹
  • 關於出版商
簡介目錄
Product Code: CMI3919

Combination products are therapeutic and diagnostic products that combine drugs, devices and/or biological products, leading to safer and more effective treatments. Combination products include at least two products, one, of medical device and other of drugs that work in coordination to treat. Thus, there is an increase in demand for drug device combination products.

Market Dynamics:

Rise in burden of chronic disorders, growing geriatric population, favorable government policies or initiatives to ensure patient safety, the outbreak of COVID-19 (pandemic), and the introduction of novel products by market players are major factors expected to drive growth of the global drug device combination product market over the forecast period.

For instance, according to the Centers for Disease Control and Prevention (CDC), 6 in 10 people in the United States live with at least one chronic disease, such as heart disease and stroke, cancer, or diabetes. These and other chronic diseases are the leading causes of death and disability in the U.S., and they are also a leading driver of health care costs.

Moreover, in October 2020, Medtronic received the U.S. Food and Drug Administration (FDA) approval for the Abre Venous Self-Expanding Stent System. The system is indicated for use in the iliofemoral veins in patients with symptomatic iliofemoral venous outflow obstruction.

Key features of the study:

  • This report provides in-depth analysis of the global drug device combination product market, and provides market size (US$ Million) and compound annual growth rate (CAGR %) for the forecast period (2022-2028), considering 2021 as the base year.
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
  • It profiles key players in the global drug device combination product market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies.
  • Key companies covered as a part of this study include AbbVie Inc. (Allergan), Terumo Corporation, GlaxoSmithKline PLC, Novartis AG, Medtronic PLC, Abbott Laboratories, Boston Scientific Corp., W L Gore and Associates Inc., Stryker Corporation, and Becton, Dickinson and Company, among others.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
  • The global drug device combination product market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global drug device combination product market.

Detailed Segmentation:

  • Global Drug Device Combination Product Market, By Products:
    • Drug Eluting Stents
    • Transdermal Patches
    • Infusion Pumps
    • Drug Eluting Balloon
    • Inhalers
    • Other Products
  • Global Drug Device Combination Product Market, By Application:
    • Cardiovascular
    • Diabetes
    • Cancer Treatment
    • Respiratory Diseases
    • Other Applications
  • Global Drug Device Combination Product Market, By End-Users:
    • Hospitals
    • Ambulatory Surgical Centers
    • Other End-Users
  • Global Drug Device Combination Product Market, By Geography:
    • North America
    • Europe
    • Asia-Pacific
    • Middle East and Africa
    • South America
  • Company Profiles:
    • AbbVie Inc. (Allergan)
    • Terumo Corporation
    • GlaxoSmithKline PLC
    • Novartis AG
    • Medtronic PLC
    • Abbott Laboratories
    • Boston Scientific Corp.
    • W L Gore and Associates Inc.
    • Stryker Corporation
    • Becton, Dickinson and Company

Table of Contents:

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snapshot, By Products
    • Market Snapshot, By Application
    • Market Snapshot, By End-Users
    • Market Snapshot, By Geography
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Increase in burden of chronic disorders
    • Product recalls and associated complications
    • Outbreak of COVID-19 (global pandemic)
  • Impact Analysis
  • Key Highlights
  • Regulatory Scenario
  • Product launch/Approvals
  • PEST Analysis
  • PORTER's Analysis
  • Merger and Acquisition Scenario

4. Global Drug Device Combination Product Market - Impact of Coronavirus (COVID-19) Pandemic

  • COVID-19 Epidemiology
  • Supply Side and Demand Side Analysis
  • Economic Impact

5. Global Drug Device Combination Product Market, By Products, 2017-2028, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2022 and 2028 (%)
    • Y-o-Y Growth Analysis, 2017 - 2028
    • Segment Trends
  • Drug Eluting Stents
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)
  • Transdermal Patches
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)
  • Infusion Pumps
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)
  • Drug Eluting Balloon
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)
  • Inhalers
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)
  • Other Products
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)

6. Global Drug Device Combination Product Market, By Application, 2017-2028, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2022 and 2028 (%)
    • Y-o-Y Growth Analysis, 2017 - 2028
    • Segment Trends
  • Cardiovascular
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)
  • Diabetes
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)
  • Cancer Treatment
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)
  • Respiratory Diseases
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)
  • Other Applications
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)

7. Global Drug Device Combination Product Market, By End Users, 2017-2028, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2022 and 2028 (%)
    • Y-o-Y Growth Analysis, 2017 - 2028
    • Segment Trends
  • Hospitals
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)
  • Ambulatory Surgical Centers
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)
  • Other End Users
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)

8. Global Drug Device Combination Product Market, By Geography, 2017-2028, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2022 and 2028 (%)
    • Y-o-Y Growth Analysis, 2017 - 2028
    • Segment Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017-2028,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2028,(US$ Mn)
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017-2028,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2028,(US$ Mn)
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017-2028,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2028,(US$ Mn)
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017-2028,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2028,(US$ Mn)
  • Middle East and Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017-2028,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2028,(US$ Mn)
  • Rest of World
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017-2028,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2028,(US$ Mn)

9. Competitive Landscape

  • AbbVie Inc. (Allergan)
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Terumo Corporation
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • GlaxoSmithKline PLC
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Novartis AG
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Medtronic PLC
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Abbott Laboratories
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Boston Scientific Corp.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • W L Gore and Associates Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Stryker Corporation
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Becton, Dickinson and Company
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Analyst Views

10. Section

  • Research Methodology
  • About us